Stuart A. Arbuckle - Aug 15, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Joy Liu, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Aug 15, 2022
Transactions value $
-$5,716,740
Form type
4
Date filed
8/17/2022, 05:39 PM
Previous filing
Aug 12, 2022
Next filing
Dec 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $1.02M +6.57K +10.79% $155.57 67.5K Aug 15, 2022 Direct
transaction VRTX Common Stock Sale -$377K -1.25K -1.86% $300.30 66.2K Aug 15, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$1.28M -4.24K -6.41% $301.61 62K Aug 15, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$121K -400 -0.65% $302.55 61.6K Aug 15, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$711K -2.34K -3.8% $303.78 59.2K Aug 15, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$2.13M -6.99K -11.8% $304.67 52.2K Aug 15, 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale -$2.12M -6.95K -13.3% $305.38 45.3K Aug 15, 2022 Direct F1, F2, F8
holding VRTX Common Stock 140 Aug 15, 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -6.57K -100% $0.00* 0 Aug 15, 2022 Common Stock 6.57K $155.57 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
F2 Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $300.30 (range $300.00 to $300.73).
F4 Open market sales reported on this line occurred at a weighted average price of $301.61 (range $301.09 to $302.01).
F5 Open market sales reported on this line occurred at a weighted average price of $302.55 (range $302.13 to $302.90).
F6 Open market sales reported on this line occurred at a weighted average price of $303.78 (range $303.13 to $304.09).
F7 Open market sales reported on this line occurred at a weighted average price of $304.67 (range $304.13 to $305.12).
F8 Open market sales reported on this line occurred at a weighted average price of $305.38 (range $305.13 to $305.83).
F9 Fully vested.